Selected article for: "common cold and high flow"
Author: van de Hei, Susanne; McKinstry, Steven; Bardsley, George; Weatherall, Mark; Beasley, Richard; Fingleton, James
Title: Randomised controlled trial of rhinothermy for treatment of the common cold: a feasibility study
  • Document date: 2018_3_27
    • ID: iys2ezkd_33
    Snippet: Conclusions: This study shows that an RCT of rhinothermy compared with low-dose vitamin C 50 in the treatment of the common cold is feasible. A robust adequately powered RCT is needed, 51 particularly as this feasibility study identified that rhinothermy improved symptoms of the 52 common cold compared with control. 53 • This is the first study investigating the use of rhinothermy delivered via high flow nasal 59 cannulae for the treatment of t.....
    Document: Conclusions: This study shows that an RCT of rhinothermy compared with low-dose vitamin C 50 in the treatment of the common cold is feasible. A robust adequately powered RCT is needed, 51 particularly as this feasibility study identified that rhinothermy improved symptoms of the 52 common cold compared with control. 53 • This is the first study investigating the use of rhinothermy delivered via high flow nasal 59 cannulae for the treatment of the common cold 60

    Search related documents:
    Co phrase search for related documents
    • common cold and feasibility study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
    • common cold and flow nasal: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • common cold and high flow nasal: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • common cold and low dose: 1, 2, 3, 4, 5, 6
    • common cold treatment and feasibility study: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • common cold treatment and flow nasal: 1, 2, 3, 4, 5, 6
    • common cold treatment and high flow nasal: 1, 2, 3, 4, 5, 6
    • common cold treatment and low dose: 1, 2, 3, 4, 5
    • control compare and low dose: 1
    • feasibility study and flow nasal: 1, 2, 3, 4
    • feasibility study and high flow nasal: 1, 2, 3, 4
    • feasibility study and improve symptom: 1
    • feasibility study and low dose: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • flow nasal and high flow nasal: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • flow nasal and low dose: 1, 2, 3, 4, 5, 6
    • high flow nasal and low dose: 1, 2, 3, 4, 5, 6
    • improve symptom and low dose: 1